Insmed Inc at Barclays Global Healthcare Conference Transcript
Hi, everyone. Thanks for joining us. My name is Leiyang Wang, and I'm covering SMID Cap file over here at Barclays. I'm pleased to be joined by Sara Bonstein, the Chief Financial Officer of Insmed. Sara, thank you for joining us.
Yes, thanks us for having us. Really appreciate it.
Definitely. So you want to do a little intro with -- about Insmed and then we can get into questions?
Sure. So I'll be happy to give you an overview of -- a high-level overview of the company. As you know, our focus is a serious and rare diseases. And what I -- as we think about our North Star, the patient, it's really about how do we develop either best-in-class, first-in-class, best-in-disease, first-in-disease drugs with the impact to our patients hope have best
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
